Review article · 2024 · Open access

α‐Synuclein in Parkinson's Disease: From Bench to Bedside

Gabriele Bellini, Vanessa D’Antongiovanni, Giovanni Palermo, Luca Antonioli, Matteo Fornai, Roberto Ceravolo, Nunzia Bernardini, Pascal Derkinderen, Carolina Pellegrini

Medicinal Research Reviews, 45(3), 909–946 · Published 20 December 2024 · DOI 10.1002/med.22091

Open PDFView at the publisherCite this paper

In brief

“α‐Synuclein in Parkinson's Disease: From Bench to Bedside” is a 2024 review article by Gabriele Bellini and 8 co-authors, published in Medicinal Research Reviews. OpenAlex counts 43 citations as of 18 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Medicinal Research Reviews.

Citations
43
Most cited in
2026 (25)
Field-weighted impact
2.61
References
267
Authors
9

Abstract

α-Synuclein (α-syn), a pathological hallmark of PD, is emerging as a bridging element at the crossroads between neuro/immune-inflammatory responses and neurodegeneration in PD. Several evidence show that pathological α-syn accumulates in neuronal and non-neuronal cells (i.e., neurons, microglia, macrophages, skin cells, and intestinal cells) in central and peripheral tissues since the prodromal phase of the disease, contributing to brain pathology. Indeed, pathological α-syn deposition can promote neurogenic/immune-inflammatory responses that contribute to systemic and central neuroinflammation associated with PD. After providing an overview of the structure and functions of physiological α-syn as well as its pathological forms, we review current studies about the role of neuronal and non-neuronal α-syn at the crossroads between neuroinflammation and neurodegeneration in PD. In addition, we provide an overview of the correlation between the accumulation of α-syn in central and peripheral tissues and PD, related symptoms, and neuroinflammation. Special attention was paid to discussing whether targeting α-syn can represent a suitable therapeutical approach for PD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bellini, G., D’Antongiovanni, V., Palermo, G., Antonioli, L., Fornai, M., Ceravolo, R., Bernardini, N., Derkinderen, P., & Pellegrini, C. (2024). α‐Synuclein in Parkinson's Disease: From Bench to Bedside. Medicinal Research Reviews, 45(3), 909–946. https://doi.org/10.1002/med.22091

MLA 9

Bellini, Gabriele, et al. “α‐Synuclein in Parkinson's Disease: From Bench to Bedside.” Medicinal Research Reviews, vol. 45, no. 3, 2024, pp. 909–946. https://doi.org/10.1002/med.22091.

Chicago

Bellini, Gabriele, Vanessa D’Antongiovanni, Giovanni Palermo, Luca Antonioli, Matteo Fornai, Roberto Ceravolo, Nunzia Bernardini, Pascal Derkinderen, and Carolina Pellegrini. 2024. “α‐Synuclein in Parkinson's Disease: From Bench to Bedside.” Medicinal Research Reviews 45 (3): 909–946. https://doi.org/10.1002/med.22091.

Harvard

Bellini, G. et al. (2024) ‘α‐Synuclein in Parkinson's Disease: From Bench to Bedside’, Medicinal Research Reviews, 45(3), pp. 909–946. doi:10.1002/med.22091.

IEEE

G. Bellini et al., “α‐Synuclein in Parkinson's Disease: From Bench to Bedside,” Medicinal Research Reviews, vol. 45, no. 3, pp. 909–946, 2024, doi: 10.1002/med.22091.

BibTeX

@article{bellini2024synuclein,
  title     = {{α‐Synuclein in Parkinson's Disease: From Bench to Bedside}},
  author    = {Bellini, Gabriele and D’Antongiovanni, Vanessa and Palermo, Giovanni and Antonioli, Luca and Fornai, Matteo and Ceravolo, Roberto and Bernardini, Nunzia and Derkinderen, Pascal and Pellegrini, Carolina},
  journal   = {Medicinal Research Reviews},
  year      = {2024},
  volume    = {45},
  number    = {3},
  pages     = {909--946},
  doi       = {10.1002/med.22091},
  url       = {https://doi.org/10.1002/med.22091}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments

  • alpha-synuclein
  • Parkinson's disease
  • neuroinflammation
  • neurodegeneration
  • microglia
  • macrophages
  • prodromal Parkinson's disease
  • immune-inflammatory response

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Bellini, G., D’Antongiovanni, V., Palermo, G., Antonioli, L., Fornai, M., Ceravolo, R., Bernardini, N., Derkinderen, P., & Pellegrini, C. (2024). α‐Synuclein in Parkinson's Disease: From Bench to Bedside. Medicinal Research Reviews, 45(3), 909–946. https://doi.org/10.1002/med.22091

How many times has this paper been cited?

43 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Medicinal Research Reviews: sign in and open the PDF from this page.

Who wrote this paper?

Gabriele Bellini, Vanessa D’Antongiovanni, Giovanni Palermo, Luca Antonioli, Matteo Fornai, Roberto Ceravolo, Nunzia Bernardini, Pascal Derkinderen, Carolina Pellegrini.

What is the DOI of this paper?

10.1002/med.22091, permanently at https://doi.org/10.1002/med.22091. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.